During the past decade, Jichi Medical University Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 9 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jichi Medical University Hospital" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Puma Biotechnology, Inc." with 3 trials sponsored, "Incyte Corporation" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Arcagy Research" with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jichi Medical University Hospital" #1 collaborator was "Medtronic" with 2 trials as a collaborator, "Medtronic Japan Co., Ltd." with 2 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator and "Belgian Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Jichi Medical University Hospital" are "Breast Cancer" (3 trials), "Coronary Artery Disease" (2 trials), "Heart Failure" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials) and "Myocardial Ischemia" (2 trials). Many other conditions were trialed in "Jichi Medical University Hospital" in a lesser frequency.

Most popular intervention types in "Jichi Medical University Hospital" are "Drug" (22 trials), "Device" (4 trials), "Other" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Atezolizumab" (2 trials), "Neratinib" (2 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials) and "17mm MDT-2215 aortic valve bioprosthesis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jichi Medical University Hospital" are 23 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Jichi Medical University Hospital". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Jichi Medical University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Jichi Medical University Hospital, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".